This chronic lung condition causes your airways to become permanently widened and scarred. Learn how to spot and treat this ...

Brensocatib, the first FDA-approved medication to treat non-cystic fibrosis bronchiectasis, can reduce symptoms of the ...

The MHRA has licensed brensocatib as the first disease-specific therapy for non-cystic fibrosis bronchiectasis in patients with recurrent exacerbations.

The Medicines and Healthcare products Regulatory Agency has granted marketing authorisation for brensocatib, branded as Brinsupri, marking the first time a medicine specifically designed to treat ...

Insmed Incorporated ( INSM) Leerink Global Healthcare Conference 2026 March 10, 2026 8:00 AM EDT Good morning. Welcome to this fireside chat with Insmed. I'm Joe Schwartz from the biopharma equity ...

SpliSense, a clinical-stage biotechnology company developing transformative RNA-based therapies for pulmonary diseases, today announced that the European Medicines Agency (EMA) has granted early ...

Full-day postgraduate and advanced trainee workshops scheduled for 27 March 2026 at Perth Convention Centre, focusing on strengthening ...

Hands are seen as a sign of grooming and personality. But doctors say nails do much more than complete a polished appearance. They can quietly reflect what is happening inside the body.Nails grow ...

Doctors weren't sure if they were dealing with a mass or a foreign object, but "it looked like a toy traffic cone." ...

A new technique to safely scan children’s lungs, an ambitious project to restore hearing loss and improving the employment ...

Electromed Inc. (NYSEAMERICAN:ELMD) is one of the most promising micro-cap stocks according to analysts. On February 10, ...